Multiomics analysis and prognostic modeling reveal the molecular features and potential therapeutic targets of breast cancer brain metastasis
Clinical and Experimental Medicine · 2025
DOI: 10.1007/s10238-025-02003-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Medicine, 2025. Verfasst von Da He und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Affiliated Hospital of Guizhou Medical University, No.16 Beijing Road, Guiyang, Guizhou, 550004, People's Republic of…. Hauptthemen laut MEDLINE: Brain Neoplasms, Breast Neoplasms. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guizhou Provincial Joint Fund for High-Quality Development of Health and Medical Research Program, Guizhou Provincial Basic Research Program (Natural Science) General Program, Doctoral Research Initiation Funds Project of The Second People's Hospital of Guiyang (Jinyang Hospital).
Abstract (Originalsprache)
Breast cancer brain metastasis (BCBM) is a major cause of poor prognosis in breast cancer, driven by complex molecular mechanisms. Innovative diagnostic and therapeutic strategies are urgently needed. We integrated single-cell RNA sequencing, multiomics profiling from the TCGA database, and machine learning to explore the molecular features of BCBM. Cell composition, gene expression, and subtypes were characterized. Prognostic models were developed, and potential drug targets were computationally identified through analysis of differentially expressed genes and molecular interactions. Experimental validation of these targets was performed using orthotopic implantation of MDA-MB-231-Luc cells in nude mice. scRNA-seq revealed 10 cell types and 1,479 differentially expressed genes, highlighting significant differences between the primary brain cancer and BCBM. Multiomics clustering defined two distinct subtypes (CS1 and CS2) with differential prognosis. A CoxBoost + RSF model identified hub genes (BTG2, PSMB8, SRGN, HLA-DPB1) and demonstrated high predictive accuracy for 3-, 5-, and 10-year survival (AUCs: 0.813, 0.788, and 0.776, respectively). Drug sensitivity analysis highlighted five candidate agents, with molecular docking confirming strong binding affinity to targeted proteins. In vivo experiments confirmed that PSMB8 and HLA-DPB1 promoted brain metastasis, while BTG2 and SRGN suppressed it. High-risk patients exhibited elevated monocyte proportions, which were involved in intercellular interactions. This study delineates the molecular landscape of BCBM, establishes robust prognostic models, and identifies promising therapeutic targets, offering a framework for precision diagnosis and individualized treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The Affiliated Hospital of Guizhou Medical University, No.16 Beijing Road, Guiyang, Guizhou, 550004, People's Republic of China.
- Department of Neurosurgery, The Second People's Hospital of Guiyang (Jinyang Hospital), No. 547 Jinyang South Road, Guanshanhu District, Guiyang, Guizhou, 550081, People's Republic of China.
- Department of Neurosurgery, The Affiliated Hospital of Guizhou Medical University, No.16 Beijing Road, Guiyang, Guizhou, 550004, People's Republic of China. chuliangzhao@yeah.net.
Förderung
- Guizhou Provincial Joint Fund for High-Quality Development of Health and Medical Research Program
- Guizhou Provincial Basic Research Program (Natural Science) General Program
- Doctoral Research Initiation Funds Project of The Second People's Hospital of Guiyang (Jinyang Hospital)
- the Guizhou Provincial Eighth Batch of High-Level Innovative Talents Training Program in Guiyang
- Doctoral Research Initiation Funds Project of The Second People’s Hospital of Guiyang
Zitieren
APA
He, D., Huang, G., Jia, X., Yu, Y., Ge, X., & Chu, L. (2025). Multiomics analysis and prognostic modeling reveal the molecular features and potential therapeutic targets of breast cancer brain metastasis. Clinical and Experimental Medicine. https://doi.org/10.1007/s10238-025-02003-4
Vancouver
He D, Huang G, Jia X, Yu Y, Ge X, Chu L. Multiomics analysis and prognostic modeling reveal the molecular features and potential therapeutic targets of breast cancer brain metastasis. Clinical and Experimental Medicine. 2025. doi:10.1007/s10238-025-02003-4
BibTeX
@article{He2025,
author = {He, Da and Huang, Guanyou and Jia, Xin and Yu, Yong and Ge, Xuecheng and Chu, Liangzhao},
title = {Multiomics analysis and prognostic modeling reveal the molecular features and potential therapeutic targets of breast cancer brain metastasis},
journal = {Clinical and Experimental Medicine},
year = {2025},
doi = {10.1007/s10238-025-02003-4}
}
EUVIMED